Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2021

01-06-2021 | Ulcerative Colitis | Original Article

Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease

Authors: Lesley Dibley, Ailsa Hart, Julie Duncan, Charles H. Knowles, Sally Kerry, Doris Lanz, Vichithranie W. Madurasinghe, Tiffany Wade, Helen Terry, Azmina Verjee, Mandy Fader, Christine Norton

Published in: Digestive Diseases and Sciences | Issue 6/2021

Login to get access

Abstract

Objectives

To test two methods for reporting of fecal incontinence (FI) in people with inflammatory bowel disease.

Methods

Consecutive patients from IBD clinics in six UK hospitals completed a short three-item case-finding survey about FI; they either completed the survey themselves or were asked the same questions face to face by a clinician.

Results

Of 1336 eligible patients with complete data (48% male; mean 43 years; 55% Crohn’s disease, 41% ulcerative colitis), 772 were asked about FI face to face, and 564 self-completed the survey: FI was reported in 63% and 56%, respectively (p = 0.012). In regression analyses, those aged 51–60, having Crohn’s disease and higher disease activity, were more likely to report FI. Of all respondents, 38.7% were interested in receiving help for their incontinence.

Conclusions

Fecal incontinence affects the majority of people with IBD. Although more patients reported fecal incontinence when asked face to face than self-reported, routine screening by either method in clinical practice is recommended. Over one-third of patients with IBD want help for bowel control problems.
Literature
1.
go back to reference Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A. Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24:1280–1290.CrossRef Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A. Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24:1280–1290.CrossRef
2.
go back to reference Macmillan AK, Merrie AEH, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47:1341–1349.CrossRef Macmillan AK, Merrie AEH, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47:1341–1349.CrossRef
3.
go back to reference Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137:e2.CrossRef Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137:e2.CrossRef
4.
go back to reference Norton C, Dibley LB, Bassett P. Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life. J Crohns Colitis. 2013;7:e302–e311.CrossRef Norton C, Dibley LB, Bassett P. Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life. J Crohns Colitis. 2013;7:e302–e311.CrossRef
5.
go back to reference Subasinghe D, Navarathna N, Samarasekera DN. Faecal incontinence and health related quality of life in inflammatory bowel disease patients: findings from a tertiary care center in South Asia. World J Gastroenterol. 2016;7:447–452. Subasinghe D, Navarathna N, Samarasekera DN. Faecal incontinence and health related quality of life in inflammatory bowel disease patients: findings from a tertiary care center in South Asia. World J Gastroenterol. 2016;7:447–452.
6.
go back to reference Lönnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life: discovering the true impact. J Crohns Colitis. 2014;8:1281–1286.CrossRef Lönnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life: discovering the true impact. J Crohns Colitis. 2014;8:1281–1286.CrossRef
7.
go back to reference Pihl Lesnovska K, Hollman Frisman G, Hjortswang H, Börjeson S. Critical situations in daily life as experienced by patients with inflammatory bowel disease. Gastroenterol Nurs. 2016;39:195–203.CrossRef Pihl Lesnovska K, Hollman Frisman G, Hjortswang H, Börjeson S. Critical situations in daily life as experienced by patients with inflammatory bowel disease. Gastroenterol Nurs. 2016;39:195–203.CrossRef
8.
go back to reference Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450–1462.CrossRef Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450–1462.CrossRef
9.
go back to reference Jelsness-Jorgensen L-P, Moum M, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;10:492034. Jelsness-Jorgensen L-P, Moum M, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;10:492034.
11.
go back to reference Farrell D, McCarthy G, Savage E. Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A. Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10:315–322.CrossRef Farrell D, McCarthy G, Savage E. Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A. Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10:315–322.CrossRef
12.
go back to reference Hart AL, Lomer M, Verjee A, et al. What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance. J Crohns Colitis. 2017;11:204–211.CrossRef Hart AL, Lomer M, Verjee A, et al. What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance. J Crohns Colitis. 2017;11:204–211.CrossRef
14.
go back to reference Duncan J, Sebepos-Rogers G, Poole-Wilson O, et al. Faecal incontinence in inflammatory bowel disease: we don’t ask and they don’t tell. J Crohns Colitis. 2013;7:S106–S107.CrossRef Duncan J, Sebepos-Rogers G, Poole-Wilson O, et al. Faecal incontinence in inflammatory bowel disease: we don’t ask and they don’t tell. J Crohns Colitis. 2013;7:S106–S107.CrossRef
15.
go back to reference Buckley B. It’s the way you ask that matters: comparison of data relating to prevalence of incontinence aid use from two surveys of people with multiple sclerosis. J Wound Ostomy Cont Nurs. 2006;33:26–29.CrossRef Buckley B. It’s the way you ask that matters: comparison of data relating to prevalence of incontinence aid use from two surveys of people with multiple sclerosis. J Wound Ostomy Cont Nurs. 2006;33:26–29.CrossRef
16.
go back to reference Norton C, Dibley LB, Hart A, et al. Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials. 2015;16:444.CrossRef Norton C, Dibley LB, Hart A, et al. Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials. 2015;16:444.CrossRef
17.
go back to reference Harvey R, Bradshaw J. A simple index of Crohn’s disease activity. Lancet. 1980;8167:514.CrossRef Harvey R, Bradshaw J. A simple index of Crohn’s disease activity. Lancet. 1980;8167:514.CrossRef
18.
go back to reference Walmsley R, Ayres R, Pounder R, Allen R. A simple clinical colitis activity index. Gut. 1998;43:29–32.CrossRef Walmsley R, Ayres R, Pounder R, Allen R. A simple clinical colitis activity index. Gut. 1998;43:29–32.CrossRef
19.
go back to reference Ng K-S, Sivakumaran Y, Nasser N, et al. Faecal incontinence: community prevalence and associated factors: a systematic review. Dis Colon Rectum. 2015;58:1194–1209.CrossRef Ng K-S, Sivakumaran Y, Nasser N, et al. Faecal incontinence: community prevalence and associated factors: a systematic review. Dis Colon Rectum. 2015;58:1194–1209.CrossRef
20.
go back to reference Stansfield C. Inflammatory bowel disease nurse specialists: sailing into a perfect storm? Br J Nurs. 2019;28:278–280.CrossRef Stansfield C. Inflammatory bowel disease nurse specialists: sailing into a perfect storm? Br J Nurs. 2019;28:278–280.CrossRef
21.
go back to reference Drossman DA, Corazziarri E, Delvaux M, et al. ROME III: The Functional Gastrointestinal Disorders. 3rd ed. Yale University Section of Digestive Disease: Degnon Associates, 2006. Drossman DA, Corazziarri E, Delvaux M, et al. ROME III: The Functional Gastrointestinal Disorders. 3rd ed. Yale University Section of Digestive Disease: Degnon Associates, 2006.
23.
go back to reference Whitehead W, Simren M, Busby-Whitehead J, et al. Fecal incontinence diagnosed by the Rome IV criteria in the United States, Canada, and the United Kingdom. Clin Gastroenterol Hepatol. 2020;18:385–391.CrossRef Whitehead W, Simren M, Busby-Whitehead J, et al. Fecal incontinence diagnosed by the Rome IV criteria in the United States, Canada, and the United Kingdom. Clin Gastroenterol Hepatol. 2020;18:385–391.CrossRef
Metadata
Title
Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease
Authors
Lesley Dibley
Ailsa Hart
Julie Duncan
Charles H. Knowles
Sally Kerry
Doris Lanz
Vichithranie W. Madurasinghe
Tiffany Wade
Helen Terry
Azmina Verjee
Mandy Fader
Christine Norton
Publication date
01-06-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06418-9

Other articles of this Issue 6/2021

Digestive Diseases and Sciences 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.